Primary prevention of coronary heart disease: Selection of patients for aggressive cholesterol management

American Journal of Medicine

Volumn 107, Issue 2 SUPPL. 1, 1999, Pages 2-6

  Grundy, Scott M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT;

CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; ECHOGRAPHY; EXERCISE TOLERANCE; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; HIGH RISK PATIENT; PATIENT EDUCATION; PATIENT SELECTION; CORONARY ARTERY DISEASE; EXERCISE TEST; REVIEW;

ANTICHOLESTEREMIC AGENTS; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; EXERCISE TEST; HUMANS; PATIENT SELECTION; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS;

EID: 0032856501     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(99)00134-5     Document Type: Conference Paper

References (41)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S) . Lancet. 344:1994;1383-1389.
2. Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels Cholesterol and Recurrent Events Trial investigators . N Engl J Med. 335:1996;1001-1009.
3. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 339:1998;1349-1357.
4. Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia West of Scotland Coronary Prevention Study Group . N Engl J Med. 333:1995;1301-1307.
5. Downs J.R., Clearfield M., Whitney E., Shapiro D., Beere P.A., Gotto A.M. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels results of AFCAPS/TexCAPS . JAMA. 279:1998;1615-1622.
6. Wilson P.W.F., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation. 97:1998;1837-1847.
7. Grundy S.M., Wilhelmsen L., Rose R., Campbell R.W.F., Assman G. Coronary heart disease in high-risk populations lessons from Finland . Eur Heart J. 11:1990;462-471.
8. Grundy S.M., Balady G.J., Criqui M.H., et al. Primary prevention of coronary heart disease guidance from Framingham - a statement for healthcare professionals from the AHA Task Force on Risk Reduction . Circulation. 97:1998;1876-1887.
9. Wood D., De Backer G., Faergemann O., Graham I., Mancia G., Pyorala K. Prevention of coronary heart disease in clinical practice recommendations of the second joint task force of European and other societies on coronary prevention . Eur Heart J. 19:1998;1434-1503.
10. National Cholesterol Education Program Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol (Adult Treatment Panel II) . Circulation. 89:1994;1329-1445.
11. Anderson K.M., Castelli W.P., Levy D.L. Cholesterol and mortality 30 years of follow-up from the Framingham study . JAMA. 257:1987;2176-2180.
12. Klag M.J., Ford D.E., Mead L.A., et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med. 328:1993;313-318.
13. Austin M.A. Plasma triglyceride as a risk factor for cardiovascular disease. Can J Cardiol. 14:(B):1998;14B-17B.
14. Krauss R.M. Dense low-density lipoproteins and coronary artery disease. Am J Cardiol. 75:1995;53B-57B.
15. Maher V.M., Brown B.G. Lipoprotein(a) and coronary heart disease. Curr Opin Lipidol. 6:1995;229-235.
16. Refsum H., Ueland P.M., Nygard O., Vollset S.E. Homocysteine and cardiovascular disease. Annu Rev Med. 49:1998;31-62.
17. Emond M., Mock M.B., Davis K.B., et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 90:1994;2645-2657.
18. Bruce R.A., Fisher L.D., Hossack K.F. Validation of exercise-enhanced risk assessment of coronary heart disease events longitudinal changes in incidence in Seattle community practice . J Am Coll Cardiol. 5:1985;875-881.
19. Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Cardiol. 55:1985;16-24.
20. Gordon D.J., Ekelund L.G., Karon J.M., et al. Predictive value of the exercise tolerance test for mortality in North American men the Lipid Research Clinics Mortality Follow-up Study . Circulation. 74:1986;252-261.
21. Ekelund L.G., Suchindran C.M., McMahon R.P., et al. Coronary heart disease morbidity and mortality in hypercholesterolemic men predicted from an exercise test the Lipid Research Clinics Coronary Primary Prevention Trial . J Am Coll Cardiol. 14:1989;556-563.
22. Rautaharju P.M., Prineas R.J., Eifler W.J., et al. Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease Multiple Risk Factor Intervention Trial experience . J Am Coll Cardiol. 8:1986;1-10.
23. Criqui M.H., Coughlin S.S., Fronek A. Noninvasively diagnosed peripheral arterial disease as a predictor of mortality results from a prospective study . Circulation. 72:1985;768-773.
24. Criqui M.H., Langer R.D., Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 326:1992;381-386.
25. McDermott M.M., Feinglass J., Slavensky R., Pearce W.H. The ankle-brachial index as a predictor of survival in patients with peripheral vascular disease. J Gen Intern Med. 9:1994;445-449.
26. Sikkink C.J., van Asten W.N., van't Hof M.A., van Langen H., van der Vliet J.A. Decreased ankle-brachial indices in relation to morbidity and mortality in patients with peripheral arterial disease. Vasc Med. 2:1997;169-173.
27. Leng G.C., Fowkes F.G., Lee A.J., Dunbar J., Housley E., Ruckley C.V. Use of ankle/brachial pressure index to predict cardiovascular events and death a cohort study . BMJ. 313:1996;1440-1444.
28. Wofford J.L., Kahl F.R., Howard G.R., McKinney W.M., Toole J.F., Crouse J.R. III. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb. 11:1991;1786-1794.
29. Crouse J.R. III. Carotid and coronary atherosclerosis What are the connections? Postgrad Med. 90:1991;175-179.
30. Crouse J.R. III, Craven T.E., Hagaman A.P., Bond M.G. Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery. Circulation. 92:1995;1141-1147.
31. Visona A., Pesavento R., Lusiani L., et al. Intimal medial thickening of common carotid artery as indicator of coronary artery disease. Angiology. 47:1996;61-66.
32. Hodis H.N., Mack W.J., LaBree L., et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 128:1998;262-269.
33. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Jr. Carotid-artery intima and medial thickness as a risk factor for myocardial infarction and stroke in older adults Cardiovascular Health Study Collaborative Research Group . N Engl J Med. 340:1999;14-22.
34. Rumberger J.A., Schwartz R.S., Simons D.B., Sheedy P.F. II, Edwards W.D., Fitzpatrick L.A. Relation of coronary calcium determined by electron-beam computed tomography and lumen narrowing determined by autopsy. Am J Cardiol. 73:1994;1169-1173.
35. Rumberger J.A., Simons D.B., Fitzpatrick L.A., Sheedy P.F., Schwartz R.S. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation. 92:1995;2157-2162.
36. Rumberger J.A., Sheedy P.F. II, Breen J.F., Fitzpatrick L.A., Schwartz R.S. Electron beam computed tomography and coronary artery disease scanning for coronary artery calcification . Mayo Clin Proc. 71:1996;369-377.
37. Budoff M.J., Georgiou D., Brody A., et al. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease a multicenter study . Circulation. 93:1996;898-904.
38. Guerci A.D., Spadaro L.A., Popma J.J., et al. Relation of coronary calcium score by electron-beam computed tomography to arteriographic findings in asymptomatic and symptomatic adults. Am J Cardiol. 79:1997;128-133.
39. Schmermund A., Baumgart D., Gorge G., et al. Measuring the effect of risk factors on coronary atherosclerosis coronary calcium score versus angiographic disease severity . J Am Coll Cardiol. 31:1998;1267-1273.
40. Arad Y., Spadara L.A., Goodman K., et al. Predictive value of electron beam computed tomography of the coronary arteries 19-month follow-up of 1173 asymptomatic subjects . Circulation. 93:1996;1951-1953.
41. Guerci A.D., Spadaro L.A., Goodman K.J., et al. Comparison of electron beam computed tomography scanning and conventional risk factor assessment for the prediction of angiographic coronary artery disease. J Am Coll Cardiol. 32:1998;673-679.